Trial no.:
|
PACTR201804003261749 |
Date of Approval:
|
28/03/2018 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Epidural painless labor |
Official scientific title |
Effect of tramadol as a local anesthetic adjuvant in epidural labour analgesia: Randomized controlled study |
Brief summary describing the background
and objectives of the trial
|
Pain and agony during childbirth are quite unbearable and sometimes beyond description. The pain if not adequately controlled may affect respiratory, cardiovascular, gastrointestinal, urinary and neuroendocrine functions. Pain also reduces uteroplacental blood flow leading to altered fetal homeostasis. Effective analgesia during labor will prevent these avoidable consequences.
According to guidelines of the American Society of Anesthesiology (ASA), and American College of Obstetrics and Gynecology (ACOG), epidural analgesia is recommended in painless labor as the most flexible, effective, and least depressing to the central nervous system of the choices available. Women also may ask for alternatives to central neuraxial analgesia.
Current practice in obstetric analgesia is to combine local anesthetics with adjuvant drugs in order to maintain high efficacy and comfort while reducing individual drug doses and side effects.
Tramadol, a synthetic 4-phenylpiperidine analog of codeine, is a racemic mixture of two enantiomers, with synergistic anti-nociceptive interaction.The result is an opioid with a lack of respiratory depressant effects despite an analgesic potency that has been shown to be approximately equal to that of pethidine in some studies.
The aim of this study is to evaluate the effect of the use of tramadol as an adjuvant to local anesthetics in epidural analgesia for female patients presented for normal vaginal delivery. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Labor analgesia,Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Supportive care |
Anticipated trial start date |
20/02/2018 |
Actual trial start date |
27/02/2018 |
Anticipated date of last follow up |
26/08/2018 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|